Join
Contact

Hypertension in Pregnancy Quality Improvement Mini-Grants

The Society for Maternal-Fetal Medicine, through the Centers for Disease Control and Prevention’s Million Hearts® initiative, invites maternal-fetal medicinesubspecialists and maternal-fetal medicine fellows working in clinical practices in the United States that are engaged in preventing, diagnosing, and/or treating hypertension in pregnancy to apply for funding to improve the health and care of patients experiencing or at risk of hypertension in pregnancy. This funding is intended to support the expanded use of systems, services, policies, tools, and resources such as those championed in the Million Hearts® Hypertension in Pregnancy Change Package.


Priority will be given to applicants who demonstrate the capacity to implement quality improvement plans within the project timeline. Applicants should have specific and measurable process goals with the intention of generating lasting impacts (e.g., qualitative or quantitative outcomes).


Application submissions are due December 4, 2026, at 8:00 pm ET. We intend to fund approximately 20 applicants for up to $25,000 each. Additional information about the application process can be found here.

Learn More and Submit an Application


Project Overview
The resources provided through this opportunity are intended to support the use of systems, services, policies, tools, and resources that enhance, optimize, and expand diagnosis, prevention, and/or treatment of hypertension in pregnancy, particularly chronic hypertension. Successful applicants will demonstrate the ability to replicate or expand initiatives ideas from the Million Hearts® Hypertension in Pregnancy Change Package or otherwise employ creative solutions to improve health and care of pregnant patients experiencing or at risk of hypertensive disorders of pregnancy.

Applicants are encouraged to review the change concepts and change ideas from the Million Hearts® Hypertension in Pregnancy Change Package for examples of strategies to be implemented, scaled, or spread via this project. Possible projects may include, but are not limited to, implementing low-dose aspirin for preeclampsia prevention, coordinating care for patients with chronic hypertension, analyzing data from remote blood pressure monitoring programs, and supporting accurate blood pressure measurement by equipping examination rooms and educating teams on proper techniques.

Formal research projects cannot be funded. The United States Department of Health and Human Services Office of Research Integrity defines research as “systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge.”

Awardees will be invited to share lessons learned among participating recipients.
Eligibility

Maternal-fetal medicine (MFM) subspecialists and MFM Fellows working in clinical practices in the United States that are engaged in preventing, diagnosing, and/or treating hypertension in pregnancy.

Due Dates & Timeline

2026
November 2: Applications open

December 4: Applications close

2027
January 8: Recipients notified

January 21, 22, 26 or 27: Introductory meeting with SMFM and Q&A (virtual)

Bi-Monthly: Project check-ins with SMFM via email

TBD: Funded recipients cohort meeting (virtual)

April 30: Mid-project summary due

August 31: Final summary report due